AHMED NADIM 4
4 · Cullinan Oncology, Inc. · Filed Feb 23, 2024
Insider Transaction Report
Form 4
AHMED NADIM
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2024-02-22+320,000→ 320,000 totalExercise: $17.54Exp: 2034-02-22→ Common Stock (320,000 underlying) - Award
Common Stock
2024-02-22+160,000→ 271,550 total
Footnotes (2)
- [F1]The shares underlying the restricted stock unit vest on an annual basis over four years.
- [F2]The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.